Skip to main content
Erschienen in: Indian Journal of Surgery 5/2011

01.10.2011 | Original Article

Factors Predicting the Axillary Lymph Node Metastasis in Breast Cancer: Is Axillary Node Clearance Indicated in Every Breast Cancer Patient?

Factors Predicting the Axillary Lymphnode Metastases in Breast Cancer

verfasst von: Amrut V. Ashturkar, Gayatri S. Pathak, Sanjay D. Deshmukh, Harshal T. Pandave

Erschienen in: Indian Journal of Surgery | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

The study was carried out to find out predictors of axillary lymph node metastasis in breast cancer and to evaluate its significance in selecting the group of patients in whom axillary dissection could be avoided. Ninety-five breast cancer patients who underwent mastectomy and axillary dissection were included in the study. Factors like patient’s age, tumor size, histopathological type, histological grade and estrogen and progesterone receptor status were correlated with the axillary metastases. Out of 95 cases axillary metastasis was found in 47 (49.47%) cases. There was no correlation between patient’s age and tumor size with axillary metastasis (p > 0.05). Based on histopathological typing tumors like ductal carcinoma in situ, tubular carcinoma and mucinous carcinoma showed less tendency for axillary metastasis (p < 0.046). Association was found between histological grade and estrogen receptor and progesterone receptor positivity with presence of axillary metastasis (p < 0.001 and 0.002 respectively). The findings in this study indicate that breast cancer patients having favorable histological type, grade I tumors and estrogen and progesterone receptor negative tumor are good candidates to avoid axillary dissection.
Literatur
1.
Zurück zum Zitat Carter CL, Allen C, Henson DE (1989) Relation of tumors size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63:181–187PubMedCrossRef Carter CL, Allen C, Henson DE (1989) Relation of tumors size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63:181–187PubMedCrossRef
2.
3.
Zurück zum Zitat Tan LGL, Tan YY, Heng D, Chan MY (2005) Predictors of axillary lymph nodemetastases in women with early breast cancer in Singapore. Singapore Med J 46(12):693–697PubMed Tan LGL, Tan YY, Heng D, Chan MY (2005) Predictors of axillary lymph nodemetastases in women with early breast cancer in Singapore. Singapore Med J 46(12):693–697PubMed
4.
Zurück zum Zitat Haffty BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M et al (1997) Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691–700PubMed Haffty BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M et al (1997) Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691–700PubMed
5.
Zurück zum Zitat Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, Wilbur DC (1995) Interobserver reproducibility of the Nottinghamm modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, Wilbur DC (1995) Interobserver reproducibility of the Nottinghamm modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed
6.
Zurück zum Zitat Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009) Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer 46:73–74PubMedCrossRef Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009) Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer 46:73–74PubMedCrossRef
7.
Zurück zum Zitat Moore MP, Kinne DW (1997) Axillary lymphadenectomy:a diagnostic and therapeutic procedure. Surg Oncol 66(1):2–6CrossRef Moore MP, Kinne DW (1997) Axillary lymphadenectomy:a diagnostic and therapeutic procedure. Surg Oncol 66(1):2–6CrossRef
8.
Zurück zum Zitat Alastair M, Thompson (1999) Axillary node clearance for breast cancer. J R Coll Surg Edinb 44:111–117 Alastair M, Thompson (1999) Axillary node clearance for breast cancer. J R Coll Surg Edinb 44:111–117
9.
Zurück zum Zitat Jatoi I (1999) Management of the axilla in primary breast cancer. Surg Clin N Am 79:1061–1073PubMedCrossRef Jatoi I (1999) Management of the axilla in primary breast cancer. Surg Clin N Am 79:1061–1073PubMedCrossRef
10.
Zurück zum Zitat Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY (2009) Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? Word J Surg 33(1):54–57CrossRef Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY (2009) Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? Word J Surg 33(1):54–57CrossRef
11.
Zurück zum Zitat Tatjana Ivkoviæ-Kapicl, Milana Panjkoviæ, Dejan Ninèiæ1, Slavica Kne¾eviæ-U¹aj.Factors correlating with lymph node metastases in patients with T1 ductal invasive breast cancer. Arch Oncol 2006;14(1–2):19–22 Tatjana Ivkoviæ-Kapicl, Milana Panjkoviæ, Dejan Ninèiæ1, Slavica Kne¾eviæ-U¹aj.Factors correlating with lymph node metastases in patients with T1 ductal invasive breast cancer. Arch Oncol 2006;14(1–2):19–22
12.
Zurück zum Zitat Iwasaki Y, Fukutomi T, Akashi-Tanaka S, Nanasawa T, Tsuda H (1998) Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup. Jpn J Clin Oncol 28:601–603PubMedCrossRef Iwasaki Y, Fukutomi T, Akashi-Tanaka S, Nanasawa T, Tsuda H (1998) Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup. Jpn J Clin Oncol 28:601–603PubMedCrossRef
13.
Zurück zum Zitat Henson DE (1988) Histological grading of breast cancer: Significance of grade on recurrence and mortality. Arch Pathol Lab Med 112:1091–1096PubMed Henson DE (1988) Histological grading of breast cancer: Significance of grade on recurrence and mortality. Arch Pathol Lab Med 112:1091–1096PubMed
14.
Zurück zum Zitat Hapton DS, Thorogood J, Clayden AD (1989) Histological grading of breast cancer: significance of grade on recurrence and mortality. Eur J Surg Oncol 15:25–31 Hapton DS, Thorogood J, Clayden AD (1989) Histological grading of breast cancer: significance of grade on recurrence and mortality. Eur J Surg Oncol 15:25–31
15.
Zurück zum Zitat Tot T (2002) Assessment of the most important prognostic factors. In: Tot T, Tabar L, Dean P (eds) Practical breast pathology. Thieme Medical Publishers, New York, pp 125–135 Tot T (2002) Assessment of the most important prognostic factors. In: Tot T, Tabar L, Dean P (eds) Practical breast pathology. Thieme Medical Publishers, New York, pp 125–135
16.
Zurück zum Zitat Aye Thike; Mei Jiuan Chng; Stephanie Fook-Chong; Puay Hoon Tan (2001) Immunohistochemical expression of hormone receptors invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 33(1):21–25 Aye Thike; Mei Jiuan Chng; Stephanie Fook-Chong; Puay Hoon Tan (2001) Immunohistochemical expression of hormone receptors invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 33(1):21–25
17.
Zurück zum Zitat Viale G, Zurrida S, Maiorano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500PubMedCrossRef Viale G, Zurrida S, Maiorano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500PubMedCrossRef
18.
Zurück zum Zitat Hlgreno J, Tal L, Estman G, Nesson L-G (1994) Prediction of axillary lymph node metastases in screened breast cancer population. Acta Oncol 33(6):603–608CrossRef Hlgreno J, Tal L, Estman G, Nesson L-G (1994) Prediction of axillary lymph node metastases in screened breast cancer population. Acta Oncol 33(6):603–608CrossRef
19.
Zurück zum Zitat Pavlista D, Dusková M, Novotný J, Zikán M, Strunová M, Freitag P, Zivný J (2002) Complications of axillary dissection in breast carcinoma. Ceská Gynekol 67(6):333–337PubMed Pavlista D, Dusková M, Novotný J, Zikán M, Strunová M, Freitag P, Zivný J (2002) Complications of axillary dissection in breast carcinoma. Ceská Gynekol 67(6):333–337PubMed
20.
Zurück zum Zitat Ponzone R, Biglia N, Maggiorotto F, Kubatzki F, Elia O, De Rosa G, Sismondi P (2003) Sentinel node dissection as definitive treatment fornode negative breast cancer patients. EJSO 29:703–706PubMedCrossRef Ponzone R, Biglia N, Maggiorotto F, Kubatzki F, Elia O, De Rosa G, Sismondi P (2003) Sentinel node dissection as definitive treatment fornode negative breast cancer patients. EJSO 29:703–706PubMedCrossRef
21.
Zurück zum Zitat Jaderborg JM, Harrison PB, Kiser JL (1999) Maynard SL The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg 65(8):699–705PubMed Jaderborg JM, Harrison PB, Kiser JL (1999) Maynard SL The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg 65(8):699–705PubMed
22.
Zurück zum Zitat Rehman S, Sardi A, Spiegler E, Coandrea J, Frishberg D (1999) Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study. Md Med J 48(3):105–110PubMed Rehman S, Sardi A, Spiegler E, Coandrea J, Frishberg D (1999) Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study. Md Med J 48(3):105–110PubMed
23.
Zurück zum Zitat Weaver DI, Karg DN, Ashikaga T, Harlow SP, O’Connell M (2000) Pathologic analysis of sentinel and non-sentinel lymph nodes in breastcarcinoma: a multicenter study. Cancer 88(5):1099–1107PubMedCrossRef Weaver DI, Karg DN, Ashikaga T, Harlow SP, O’Connell M (2000) Pathologic analysis of sentinel and non-sentinel lymph nodes in breastcarcinoma: a multicenter study. Cancer 88(5):1099–1107PubMedCrossRef
Metadaten
Titel
Factors Predicting the Axillary Lymph Node Metastasis in Breast Cancer: Is Axillary Node Clearance Indicated in Every Breast Cancer Patient?
Factors Predicting the Axillary Lymphnode Metastases in Breast Cancer
verfasst von
Amrut V. Ashturkar
Gayatri S. Pathak
Sanjay D. Deshmukh
Harshal T. Pandave
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Surgery / Ausgabe 5/2011
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-011-0315-5

Weitere Artikel der Ausgabe 5/2011

Indian Journal of Surgery 5/2011 Zur Ausgabe

Letter to Editor

Letter to the Editor

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.